U.S. flag

An official website of the United States government

Display Settings:

Format

Send to:

Choose Destination
Mavacamten (Camzyos): CADTH Reimbursement Recommendation: Indication: For the treatment of symptomatic obstructive hypertrophic cardiomyopathy of New York Heart Association class II to III in adult patients [Internet].

Mavacamten (Camzyos): CADTH Reimbursement Recommendation: Indication: For the treatment of symptomatic obstructive hypertrophic cardiomyopathy of New York Heart Association class II to III in adult patients [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 May.

Table of contents


Supplemental Content

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...